As of May 2024 Xencor has a market cap of $1.31 Billion. This makes Xencor the world's 4796th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.31 B | 1.82% |
2023 | $1.29 B | -17.18% |
2022 | $1.56 B | -33.49% |
2021 | $2.34 B | -6.4% |
2020 | $2.50 B | 28.1% |
2019 | $1.95 B | -3.84% |
2018 | $2.03 B | 97.7% |
2017 | $1.02 B | -15.73% |
2016 | $1.22 B | 106.05% |
2015 | $0.59 B | 17.58% |
2014 | $0.50 B | 75.94% |
2013 | $0.28 B |
On May 14th, 2024 the market cap of Xencor was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $364.32 B | 27,586.68% | ๐บ๐ธ USA |
AbbVie ABBV | $285.34 B | 21,584.89% | ๐บ๐ธ USA |
Amgen AMGN | $167.05 B | 12,595.03% | ๐บ๐ธ USA |
Merck MRK | $327.46 B | 24,785.78% | ๐บ๐ธ USA |
Seagen
SGEN | $43.15 B | 3,179.54% | ๐บ๐ธ USA |
MacroGenics MGNX | $0.27 B | -78.82% | ๐บ๐ธ USA |